Lori Doyle, PA
Medical · Manassas, VANPI 1558753293
Payments from drug & device makers
Across 163 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$698
- Dermavant Sciences, Inc.$469
- AbbVie$432
- Lilly USA, LLC$376
- Novartis$210
- UCB, Inc.$169
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,53694%
- Education$2376%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $698 |
| Dermavant Sciences, Inc. | 10 | $469 |
| AbbVie(2 entities) | 24 | $432 |
| Lilly USA, LLC | 16 | $376 |
| Novartis | 10 | $210 |
| UCB, Inc. | 7 | $169 |
| Incyte Corporation | 4 | $152 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $149 |
| Amgen | 6 | $139 |
| Merz North America, Inc. | 1 | $128 |
| Pfizer | 6 | $116 |
| Galderma Laboratories, L.p. | 6 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Almirall LLC | 6 | $95 |
| LEO Pharma Inc. | 6 | $91 |
| E.r. Squibb & Sons, L.L.C. | 4 | $81 |
| Sun Pharmaceutical Industries Inc. | 4 | $80 |
| Sanofi | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| EPI Health, LLC | 2 | $30 |
| Journey Medical Corporation | 2 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Organon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,773 in reported general payments places this provider in the 85th percentile of 632 medical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 28 | $1,581 |
| Fluorouracil | 22 | $1,532 |
| Ketoconazole | 60 | $967 |
| Fluocinonide | 12 | $396 |
| Triamcinolone Acetonide | 23 | $302 |
| Mupirocin | 32 | $301 |
Paid to pharmacies, not to this prescriber.
Other medical in Manassas
- Bryan UrquhartFredericksburg$264K
- Sara VillalonaRichmond$240K
- Sarah SafaLansdowne$171K
- Waseem GarbiaFairfax$114K
- Rana HassanAshburn$54K
- Brian LamFalls Church$51K
- Christine KesslerKing George$20K
- Janlyn AnthonyRichmond$18K
- Cara DepanfilisNorfolk$17K
- Nicholas DeptulaRichmond$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.